Incorporated in 2002, Symbiotec Pharmalab Ltd. is a pharmaceutical and biotechnology company engaged in the development and manufacturing of active pharmaceutical ingredients (APIs), nutritional ingredients, and specialty products. The company serves domestic and international markets across regulated and emerging regions.
With over 30 years of industry experience, Symbiotec Pharmalab has evolved from a lab-scale steroidal hormone API manufacturer in 1995 into an industrial-scale, backward-integrated manufacturing platform. The company has approvals from the United States Food and Drug Administration (US FDA), European Union Good Manufacturing Practices (EU-GMP), Ministry of Food and Drug Safety, Korea, and other global regulatory organisations.
As of June 30, 2025, the company operated two industrial-scale API manufacturing facilities with a maximum chemical synthesis capacity of 584.67 metric tonnes (MT) and fermentation capacity of 300 kilolitres.
Symbiotec Pharmalab focuses on research-driven manufacturing, quality compliance, and sustainable production processes. It supports the pharmaceutical, nutraceutical, and wellness industries by providing high-quality ingredients aligned with global standards.
Competitive Strengths:
Symbiotec Pharmalab Ltd.’s revenue increased by 15% and profit after tax (PAT) rose by 14% between the financial year ending with March 31, 2026 and March 31, 2025.
| Period Ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 1,780.79 | 1,579.65 | 1,294.79 |
| Total Income | 872.26 | 755.98 | 723.33 |
| Profit After Tax | 109.90 | 96.79 | 100.06 |
| EBITDA | 231.97 | 206.11 | 177.04 |
| NET Worth | 1,158.64 | 821.15 | 720.68 |
| Reserves and Surplus | 1,145.95 | 810.03 | 709.54 |
| Total Borrowing | 387.91 | 540.92 | 247.21 |
| Amount in ₹ Crore | |||
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Hexagon Nutrition Ltd. | Mainboard | ₹138.87 Cr | ₹45 | 22.69 | ₹53.19 | +18.20% | ₹70.21 |
| Sai Parenteral’s Ltd. | Mainboard | ₹408.79 Cr | ₹392 | 72.19 | ₹405.70 | +3.49% | ₹540.85 |
| Corona Remedies Ltd. | Mainboard | ₹655.37 Cr | ₹1062 | 43.47 | ₹1,438.40 | +35.44% | ₹2,142.60 |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Prepayment and/or repayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the Company | 112.50 |
| 2 | General corporate purposes |
| KPI | Mar 31, 2026 | Mar 31, 2025 |
|---|---|---|
| ROE | 11.19% | 12.66% |
| ROCE | 11.56% | 11.80% |
| RoNW | 9.48% | 11.79% |
| PAT Margin | 12.60% | 12.80% |
| EBITDA Margin | 26.59% | 27.26% |
| NAV | 184.69 | 150.17 |
| Price to Book Value | 5.35 | 6.58 |
| Valuation Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 17.82 | 17.39 |
| P/E (x) | 55.44 | 56.81 |
| IPO Date | 24 to 27 Aug, 2026 |
| Listing Date | Tue, Sep 1, 2026T |
| Face Value | ₹2 per share |
| Price Band | ₹938 to ₹988 |
| Lot Size | 15 Shares |
| Sale Type | Fresh capital cum OFS |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Employee Discount | ₹90.00 |
| Total Issue Size | 1,77,86,442 shares (agg. up to ₹1,757 Cr) |
| Fresh Issue | 15,21,261 shares (agg. up to ₹150 Cr) |
| Offer for Sale | 1,62,65,181 shares of ₹2 (agg. up to ₹1,607 Cr) |
| Share Holding Pre Issue | 6,16,81,496 shares |
| Share Holding Post Issue | 6,32,02,757 shares |
As per our analysis and Based on the information we have, this is the output.
Allah knows best.
If you find this result mistaken or questionable, let us know via email at info (@) halalstock.in
The IPO dashboard offers insights on the Latest Current & Upcoming IPOs in BSE & NSE. It also evaluates IPOs for Shariah compliance, ensuring alignment with Islamic principles for ethical investment choices.
Last Updated on October 1, 2026 TNA Solutions Ltd. IPO Incorporated in September 2021, TNA Solutions Limited is engaged in the manufacturing of home textile products for domestic and international
Last Updated on October 1, 2026 Omara Ventures India Ltd. IPO Incorporated in October 2020, Omara Ventures India Limited is a retail jewellery company engaged in the sale of diamond
Last Updated on October 1, 2026 Sollfege Smart Electronics Ltd. IPO Incorporated in November 2012, Sollfege Smart Electronics Limited is engaged in the distribution, integration and implementation of premium audio,
You can contribute as little as
100, 200, 500 & so…
every bit counts.
